premature thelarche pt medical condition characterised isolated breast development female infants occurs females younger years highest occurrence age pt rare occurring females aged years exact cause condition still unknown linked variety genetic dietary physiological pt form incomplete precocious puberty ipp ipp presence secondary sex characteristic infant without change sex hormone levels central precocious puberty cpp severe condition ipp cpp presentation secondary sex characteristics change sex hormones due alteration hypothalamicpituitarygonadal hpg cpp aggressive endocrine disorder harmful developmental consequences patient presentation pt diagnostics used ensure early stage cpp cpp differentiated pt biochemical testing ultrasounds ongoing treatment pt regular observation important ensure progress cpp cpp diagnosis important treatment premature thelarche breast hypertrophy puberty form hypertrophy increase breast tissue pt occurs prepubescent females age peak occurrence first two years breast development usually bilateral breasts show development cases development may unilateral one breast developscitation needed four patterns pt development patients hypertrophy followed complete loss excess breast tissue cases loss excess tissue remains puberty cases less commonly patients ongoing patterns thelarche suffer cyclic pattern size breast tissue varies time experience continual increase tissue main symptom pt enlarged breast tissue infants estrogens role pt also leads increased bone age growth pt secondary symptoms minimal bone age varies actual age months growth velocity slightly varies norm diagnostic tests distinguish pt secondary symptoms severe bone aging growth occurring early direct pathophysiology behind pt still unknown many postulated pt linked increased sensitivity breast tissue estradiol estrogen derivative certain prepubertal sporadic estrogen estradiol production adrenal glands follicles ovarian cysts also linked follicle stimulating hormone fsh secreted anterior pituitary fsh plays key role development growth puberty thus suspected play role pt gondotropinreleasing hormone gnrh stimulation testing patients pt shown dominant response fsh response linked active mutations fsh receptor gsa subunit pt genetic investigation indicated mutations account cases premature pt may also caused transient partial activation hpg axis partial activation would release surplus fsh anterior pituitary without disruption hpg consumption exposure certain endocrine disrupters also linked pt benign growth breasts infants cpp condition involves frequent activation hpg axis patients pt require treatment condition limited enlarged breast tissue usually subsides time cpp associated wider range symptoms including thelarche pubic hair growth accelerated bone aging increased growth velocity early epiphyseal growth individual affected cpp need begin treatment immediately cpp treated lutenizing hormone lh releasing hormone agonists pt impact growth velocity bone age slightly cpp affects characteristics point detriment adult patients suspected pt must undergo diagnostic testing ensure cpp exaggerated thelarche intermediate stage notable hormone differences occur cpp pt patients studying hormone levels main biochemical diagnostic used individuals cpp usually higher basal lh levels lhfsh pt patients predicted develop observation allows clinicians identify presentation cpp indicative symptoms pt patients diagnostics tests indicate pt patient risk developing premature thelarche require treatment pt breast hypertrophy usually stop completely patients experience regression breast tissue months less commonly patients may remain residual breast tissue continue cycles breast hypertrophy regression diagnostics utilised individuals pt especially presentation secondary sex characteristics diagnostics aim ensure pt patients suffering pelvic ultrasounds important diagnosing patients cpp increased ovary uterus size ovary uterus volume cpp patients similar females undergoing pelvis ultrasound problematic diagnostic specific cutoff uterine ovary volumes indicate patient cpp patients pt uterine ovarian volume within normal range age pelvic ultrasounds desirable diagnostic noninvasive easy continually review pelvic ultrasound paired biochemical tests determine presence biochemical tests study hormone levels patients cpp patients elevated lh levels peak lhfsh ratios compared pt patients hard use lh diagnostic cpp lh assay varying sensitivity gnrh stimulation test main diagnostic biochemical test used distinguish pt gnrh test demonstrates pituitary responsiveness gnrh gnrh stimulates release lh fsh anterior pituitary peak lhfsh ratio cpp patients similar ratio pubertal females females pt demonstrated lhfsh ratio lower pubertal disadvantages gnrh stimulation test takes long time perform requires multiple collections patient making process time consuming inconvenient test highly specific low sensitivity lh hormone response usually observed later stages also overlaps expected value gnrh test results individuals cpp diagnostic inconsistency cpp means combination pelvic ultrasounds biochemical tests paired observation ensure pt progress natural commodities like fennel lavender tea tree oils linked pt lavender tea tree oil weak estrogenic activities estrogenic properties may cause imbalance endocrine signalling pathways leading pt regular users fennel tea studied endocrine disrupter linked pt fennel seed oil contains anethole compound estrogenic effects tea contains fennel seed oil regular use results increased estradiol levels infant infants fennel tea related pt given tea homeopathic remedy restlessness tea consumed least four months presentation pt symptoms pt resulting fennel tea subsides approximately six months stopping use fennel leptin adipocyte hormone important implications puberty sex hormone secretion increased leptin linked estrogen estradiol secretion leptin key roles maintaining age appropriate body composition desired weight leptin receptors also found mammary epithelial cells leptin observed growth factor breast tissue increased leptin levels observed cases pt increase leptin levels cause increased estradiol levels development breast form pt fluctuating hypertrophy patients linked activating mutations gene mutation accounts small number cases httpsenwikipediaorgwikiprematurethelarche